The global cell separation technologies market was valued at $8,639.20 million in 2019 and is projected to reach $28,766.14 million by 2027, registering a CAGR of 15.4% from 2020 to 2027.
Cell separation technologies involve the separation of cells from a heterogeneous cell mixture according to their intracellular or extracellular properties. Cell separation has gained importance in the fields of medicine and biology as it is an essential component of cellular therapy and disease diagnosis. Furthermore, rise in prevalence of chronic diseases such as cancer, diabetes, cardiovascular diseases (CVDs), and many others result in incorporation of cell separation technology for the purpose of both diagnostic and therapeutic. Moreover, cell separation technology preferred over pathological treatment and conventional diagnostic procedures. Using cell separation technique, root cause of any disease is predicted. And later, treatment is provided on the same basis. The technique aims at removal of disease from cell level, leaving no trace for reoccurrence of disease in future. The recent expansion of the field of cell separation is linked to an increase the mortality rate due to chronic diseases as majority of these diseases can be treated using cell-based therapies.

The growth of the global cell separation technologies market is majorly driven by increase in number of patients suffering from chronic disease and technological advancements in cell technologies. In addition, surge in focus on personalized medicines for early detection of disease, selection of appropriate treatment, and determination of the prognosis of the therapy. However, ethical issues related to embryonic stem cell separation and high cost of cell based research hinder the market growth. Conversely, high market potential in untapped emerging economies are expected to provide lucrative growth opportunities for the market growth.
The cell separation technologies market is segmented on the basis of technology, product, application, end user, and region. By product, the market is bifurcated into instruments and consumables. On the basis of technology, the cell separation technologies market is divided into gradient centrifugation, surface markers separation, and filtration based separation. Surface markers separation is further classified into fluorescence activated cell sorting and magnetic cell sorting. On the basis of application, the market is classified into oncology research, neuroscience research, stem cell research, microbiology, immunology research and other application. By end user, the market is segmented into research laboratories & institute, biotechnology & biopharmaceutical companies, and cell banks. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the key players operating in the market include Alfa Laval Corporate AB, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Corning Incorporated, Danaher Corporation, Merck KGaA, Miltenyi Biotec Inc., Pluriselect GmbH, Stemcell Technologies Inc., and Thermo Fisher Scientific.

KEY BENEFITS FOR STAKEHOLDERS

? This report entails a detailed quantitative analysis along with the current global cell separation technologies market trends from 2020 to 2027 to identify the prevailing opportunities along with the strategic assessment.
? The market forecast is studied from 2020 to 2027.
? The market size and estimations are based on a comprehensive analysis of key developments in the industry.
? A qualitative analysis based on innovative products facilitates strategic business planning.
? The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.

KEY MARKET SEGMENTS
By Product
- Instruments
- Consumables
By Technology
- Gradient Centrifugation
- Surface Markers Separation
o Fluorescence activated cell sorting
o Magnetic cell sorting
- Filtration Based Separation
By Application
- Oncology Research
- Neuroscience Research
- Stem Cell Research
- Microbiology
- Immunology Research
- Others
By End User
- Research laboratories & Institute
- Biotechnology & Biopharmaceutical Companies
- Cell Banks

By Region
- North America
o U.S.
o Canada
o Mexico
- Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
- Asia-Pacific
o Australia
o Japan
o India
o China
o Rest of Asia-Pacific
- LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA


?
KEY MARKET PLAYERS
- Alfa Laval Corporate AB
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Corning Incorporated
- Danaher Corporation
- Merck KGaA,
- Miltenyi Biotec Inc.
- Pluriselect GmbH
- Stemcell Technologies Inc.
- Thermo Fisher Scientific.
The other players (not profiled in the report) in the value chain include
- Akadeum Life Sciences
- Cytiva Lifesciences
- Terumo
- 10X Genomics
- Zeiss
- PerkinElmer, Inc.